# Tocilizumab for Relapsing Polychondritis

> **NCT01104480** · PHASE2 · WITHDRAWN · sponsor: **McMaster Children's Hospital**

## Conditions studied

- Relapsing Polychondritis

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT01104480
- **Lead sponsor:** McMaster Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-05
- **Primary completion:** 2010-07
- **Final completion:** 2012-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Tocilizumab was licenced in Canada for children, so the study was not necessary
- **Last updated:** 2014-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01104480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01104480, "Tocilizumab for Relapsing Polychondritis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01104480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*